International Clinical Trial: Dawn Path - A Social Rehabilitation Incentive Platform for Patients with Severe Mental Illness

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132241) titled 'Dawn Path - A Social Rehabilitation Incentive Platform for Patients with Severe Mental Illness' on Sept. 10.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Xiamen Xianyue Hospital

Condition: Schizophrenia

Intervention: Token incentives for the rehabilitation group:On the basis of conventional rehabilitation care, participants received a 8-week (from the 2nd week to the 8th week) structured token rehabilitation therapy.

Recruitment Status: Not Recruiting

Phase: 0

Date of First Enrollment: 2026-09-30

Target Sample Size: Token incentives for the rehabilitation group:30;Contro...